Optimizing the Use of Thrombolytics in ST-Segment Elevation Myocardial Infarction

The advent of thrombolytic therapy was a major advance in the treatment of ST-segment elevation myocardial infarction (STEMI). The administration of fibrinolytic reperfusion therapy can reduce mortality rates by as much as 30%, with the greatest benefit observed if therapy is administered soon after...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs (New York, N.Y.) N.Y.), 2009-10, Vol.69 (14), p.1945-1966
Hauptverfasser:	Morse, Michael A., Todd, Josh W., Stouffer, George A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Angioplasty Angioplasty, Balloon, Coronary - methods Aspirin Bats Biological and medical sciences Biomarkers Blood. Blood coagulation. Reticuloendothelial system Cardiology. Vascular system Clinical Protocols Clinical Trials as Topic Combined Modality Therapy Contraindications Coronary Angiography - methods Coronary heart disease Coronary Thrombosis - drug therapy Coronary Thrombosis - surgery Drug therapy Drug Therapy, Combination Electrocardiography Fibrinolytic Agents - administration & dosage Fibrinolytic Agents - therapeutic use Health aspects Heart Heart attack Heart attacks Humans Internal Medicine Literature reviews Medical sciences Medicine Medicine & Public Health Mortality Myocardial Infarction - drug therapy Myocarditis. Cardiomyopathies Pharmacokinetics Pharmacology. Drug treatments Pharmacology/Toxicology Pharmacotherapy Reperfusion - methods Review Article Thrombolytic drugs Time Factors Treatment Failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!